NASDAQ : STIM

Neuronetics, Inc. — Company profile

Healthcare · Medical Devices · United States

Last price 2.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.44M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Details

NameNeuronetics, Inc.
SectorHealthcare
IndustryMedical Devices
Employees658
Founded2003
Ipo Date2018-06-28
CeoDaniel Reuvers
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS64131A1051
Cusip64131A105
Cik0001227636
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
Daniel L. ReuversChief Executive Officer, President and Director
Nir Naor C.F.A., CPA, L.L.M., M.B.A.Executive Vice President, Chief Financial Officer, Corporate Secretary, Principal Financial and Accounting Officer and Treasurer
Robert GreeneSenior Vice President of Sales
Cory S. AndersonExecutive Vice President and General Manager of Greenbrook

Contact

Address3222 Phoenixville Pike, Malvern, Pennsylvania 19355, United States
Phone877 600 7555
Websitehttps://neurostar.com/neuronetics